Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has shared an update.
ResMed Inc has filed a Form 144 indicating a proposed sale of securities under Rule 144 of the Securities Act of 1933. The filing involves the sale of 2,000 common shares by Peter C. Farrell, a director of the company, with an aggregate market value of $500,000. The transaction reflects insider activity and may have implications for the company’s stock performance and investor perceptions.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$33.70 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
ResMed Inc is a company operating in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep disorders, such as sleep apnea, and chronic respiratory diseases. The company is known for its innovative solutions in sleep and respiratory care, catering to a global market.
Average Trading Volume: 1,299,233
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$55.74B
See more insights into RMD stock on TipRanks’ Stock Analysis page.